Skip to main content

Five Prime Therapeutics Subscribes to Gene Logic s BioExpress

NEW YORK, July 7 - Gene Logic said today that Five Prime Therapeutics has purchased a subscription to its BioExpress Custom Suite, a subset of gene expression data from the company's GeneExpress database.


Five Prime will use the data as part of its therapeutics discovery efforts. Gene Logic will also generate additional gene expression data using proprietary microarrays developed by Five Prime and will integrate the resulting data into the dataset.


Financial details of the multiyear subscription agreement were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.